Targeted Theranostic Nanoparticles: Receptor‐Mediated Entry into Cells, pH‐Induced Signal Generation and Cytosolic Delivery
Source abstract
Abstract
Virus-like theranostic nanoparticles: virus-like poly(amino acid) nanoparticles are synthesized that can be internalized via receptor-mediated endocytosis, resulting in encapsulated pH-activatable fluorescence probes that can be turned on in acidic environments but otherwise remain undetectable. The encapsulated anticancer drugs are also released into cytosol by endosome disruption.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Graduate School and Department of Analytical Science and Technology Chungnam National University Daejeon 305–764 Republic of Korea
Division of Magnetic Resonance Research Korea Basic Science Institute Cheongwon 363–883 Republic of Korea
References (47)
Show source-provided references
1. 10.1002/adma.20110014010.1002/adma.201100140 ↗
2. 10.1002/pmic.20070107210.1002/pmic.200701072 ↗
3. 10.1021/nn901877h10.1021/nn901877h ↗
4. 10.1002/anie.20070355410.1002/anie.200703554 ↗
5. 10.1002/anie.20080085710.1002/anie.200800857 ↗
6. 10.1002/anie.20120319310.1002/anie.201203193 ↗
7. 10.1021/nn300289u10.1021/nn300289u ↗
8. 10.1021/nl900872r10.1021/nl900872r ↗
9. 10.1021/ja807099s10.1021/ja807099s ↗
10. 10.1002/marc.20070079710.1002/marc.200700797 ↗
11. 10.1016/j.ab.2007.07.00710.1016/j.ab.2007.07.007 ↗
12. 10.1021/nn100295x10.1021/nn100295x ↗
13. 10.2174/15680261279891912310.2174/156802612798919123 ↗
14. 10.1016/j.nantod.2011.08.00210.1016/j.nantod.2011.08.002 ↗
15. Rawat A. · Pharmazie · 2007 · 62 · 643
16. 10.1117/1.JNP.7.07159910.1117/1.JNP.7.071599 ↗
17. 10.1021/ar200230410.1021/ar2002304 ↗
18. 10.1021/ja311180x10.1021/ja311180x ↗
19. 10.1128/JVI.02461-0910.1128/JVI.02461-09 ↗
20. 10.1128/JVI.00873-0910.1128/JVI.00873-09 ↗
21. 10.1128/JVI.02371-0910.1128/JVI.02371-09 ↗
22. 10.1021/jp208445p10.1021/jp208445p ↗
23. 10.1042/bj2002194510.1042/bj20021945 ↗
24. 10.1002/1521-3900(200107)172:1<49::AID-MASY49>3.0.CO;2-Y10.1002/1521-3900(200107)172:1<49::AID-MASY49>3.0.CO;2-Y ↗
25. 10.2174/09298671280078466710.2174/092986712800784667 ↗
26. 10.1016/j.addr.2012.09.04110.1016/j.addr.2012.09.041 ↗
27. 10.1080/0738855060116645810.1080/07388550601166458 ↗
28. 10.4049/jimmunol.179.2.77510.4049/jimmunol.179.2.775 ↗
29. 10.1007/s00262-010-0903-410.1007/s00262-010-0903-4 ↗
30. 10.1002/cbdv.20090028310.1002/cbdv.200900283 ↗
31. 10.1517/17425247.2013.75235410.1517/17425247.2013.752354 ↗
32. 10.1517/1742524090355984110.1517/17425240903559841 ↗
33. 10.1021/mp300240m10.1021/mp300240m ↗
34. 10.1021/ja043919h10.1021/ja043919h ↗
35. 10.1021/ja048241k10.1021/ja048241k ↗
36. 10.1021/ja904472z10.1021/ja904472z ↗
37. 10.1161/CIRCULATIONAHA.111.07528310.1161/CIRCULATIONAHA.111.075283 ↗
38. 10.1002/smll.20110107610.1002/smll.201101076 ↗
39. 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
40. 10.1166/jnn.2012.675510.1166/jnn.2012.6755 ↗
41. 10.1016/j.jconrel.2013.04.02010.1016/j.jconrel.2013.04.020 ↗
42. 10.1016/S0168-3659(99)00114-510.1016/S0168-3659(99)00114-5 ↗
43. Baselga J. · Cancer Res. · 1998 · 58 · 2825
44. 10.1016/S0959-8049(01)00230-110.1016/S0959-8049(01)00230-1 ↗
45. 10.1002/anie.20080246910.1002/anie.200802469 ↗
46. 10.1073/pnas.090236510610.1073/pnas.0902365106 ↗
47. 10.1016/j.jconrel.2011.05.02510.1016/j.jconrel.2011.05.025 ↗